Innate Immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Durrenberger, Pascal F ^a   Ettorre, Anna ^a   Kamel, Fatemah ^a   Webb, Louise V ^a   Sim, Malcolm ^a   Nicholas, Richard S ^b   Malik, Omar ^b   Reynolds, Richard ^a   Boyton, Rosemary J ^a   Altmann, Daniel M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Astrocyte; Autoimmune diseases; Natural killer cell; Neurodegeneration; Neuroinflammation

Indexed keywords

MESSENGER RNA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; GLUCAN; POLYGLUCOSAN;

ADULT; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN DISEASE; CANCER CELL CULTURE; CELL STRESS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INNATE IMMUNITY; MALE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; UPREGULATION; WHITE MATTER LESION; CYTOLOGY; GENETICS; LYMPHOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADULT; ASTROCYTES; ASTROCYTOMA; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; FEMALE; GLUCANS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RNA, MESSENGER;

EID: 84855185583     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-1     Document Type: Article

References (53)

1. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060. 10.1038/35059110, 11234016.
2. Walzer T, Blery M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, Andre P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagné F, Vivier E. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 2007, 104:3384-3389. 10.1073/pnas.0609692104, 1805551, 17360655.
3. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001, 19:197-223. 10.1146/annurev.immunol.19.1.197, 11244035.
4. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L, Moretta A. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med 1997, 186:1129-1136. 10.1084/jem.186.7.1129, 2211712, 9314561.
5. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998, 188:953-960. 10.1084/jem.188.5.953, 3207313, 9730896.
6. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001, 31:2680-2689. 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A, 11536166.
7. Foster CE, Colonna M, Sun PD. Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors. J Biol Chem 2003, 278:46081-46086. 10.1074/jbc.M308491200, 12960161.
8. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999, 29:1656-1666. 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1, 10359120.
9. Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro Ados S, Falcao RR, Abdelhay E, Bouzas LF, Thuler LC, Ornellas MH, Diamond HR. Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol 2011, 72:319-329. 10.1016/j.humimm.2011.01.009, 21262312.
10. Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2004, 103:664-672. 10.1182/blood-2003-05-1716, 14504081.
11. Achdout H, Manaster I, Mandelboim O. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J Virol 2008, 82:8030-8037. 10.1128/JVI.00870-08, 2519585, 18524833.
12. Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K, Hisamatsu T, Kanai T, Hibi T. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 2010, 139:882-892. 10.1053/j.gastro.2010.05.040, 20638936.
13. Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 2010, 11:121-128. 10.1038/ni.1834, 20023661.
14. Lunemann JD, Munz C. Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?. Brain 2008, 131:1681-1683. 10.1093/brain/awn132, 18586760.
15. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997, 186:1677-1687. 10.1084/jem.186.10.1677, 2199138, 9362528.
16. Winkler-Pickett R, Young HA, Cherry JM, Diehl J, Wine J, Back T, Bere WE, Mason AT, Ortaldo JR. In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J Immunol 2008, 180:4495-4506.
17. Saikali P, Antel JP, Newcombe J, Chen Z, Freedman M, Blain M, Cayrol R, Prat A, Hall JA, Arbour N. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci 2007, 27:1220-1228. 10.1523/JNEUROSCI.4402-06.2007, 17267578.
18. Lunemann A, Lunemann JD, Roberts S, Messmer B, Barreira da Silva R, Raine CS, Munz C. Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. J Immunol 2008, 181:6170-6177. 2596922, 18941207.
19. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 2000, 20:5283-5291.
20. Saraste M, Irjala H, Airas L. Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol Sci 2007, 28:121-126. 10.1007/s10072-007-0803-3, 17603762.
21. Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 2006, 103:5941-5946. 10.1073/pnas.0601335103, 1458677, 16585503.
22. Airas L, Saraste M, Rinta S, Elovaara I, Huang YH, Wiendl H, . The Finnish Multiple Sclerosis and Pregnancy Study Group Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol 2008, 151:235-243. 2276950, 18062798, The Finnish Multiple Sclerosis and Pregnancy Study Group.
23. Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T. The regulatory role of natural killer cells in multiple sclerosis. Brain 2004, 127:1917-1927. 10.1093/brain/awh219, 15229129.
24. De Jager PL, Rossin E, Pyne S, Tamayo P, Ottoboni L, Viglietta V, Weiner M, Soler D, Izmailova E, Faron-Yowe L, O'Brien C, Freeman S, Granados S, Parker A, Roubenoff R, Mesirov JP, Khoury SJ, Hafler DA, Weiner HL. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain 2008, 131:1701-1711. 10.1093/brain/awn118, 2730047, 18567923.
25. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640. 10.1016/S1471-4906(01)02060-9, 11698225.
26. Lunemann A, Tackenberg B, DeAngelis T, da Silva RB, Messmer B, Vanoaica LD, Miller A, Apatoff B, Lublin FD, Lunemann JD, Munz C. Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis. Int Immunol 2011, 23:139-148. 10.1093/intimm/dxq463, 21212154.
27. Bell JE, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Budka H, Dexter DT, Falkai P, Ferrer I, Gelpi E, Gentleman SM, Giaccone G, Huitinga I, Ironside JW, Klioueva N, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Reynolds R, Riederer P, Roggendorf W, Seilhean D, Schmitt A, Schmitz P, Streichenberger N, Schwalber A, Kretzschmar H. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol 2008, 115:497-507. 10.1007/s00401-008-0360-8, 18365220.
28. Abramoff MD, Magalhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics International 2004, 11:36-42.
29. Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, Smith C, Walker R, Al-Sarraj S, Troakes C, Palkovits M, Kasztner M, Huitinga I, Arzberger T, Dexter DT, Kretzschmar H, Reynolds R. Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol 2010, 69:70-81. 10.1097/NEN.0b013e3181c7e32f, 20010301.
30. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010, 68:477-493. 10.1002/ana.22230, 20976767.
31. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
32. Ponten J, Westermark B. Properties of human malignant glioma cells in vitro. Med Biol 1978, 56:184-193.
33. Young NT, Waller EC, Patel R, Roghanian A, Austyn JM, Trowsdale J. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 2008, 111:3090-3096. 10.1182/blood-2007-05-089771, 18094328.
34. Anderson KJ, Allen RL. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 2009, 127:8-17. 10.1111/j.1365-2567.2009.03097.x, 2678177,2678177, 19368561.
35. Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients. J Invest Dermatol 2011, 131:969-976. 10.1038/jid.2010.404, 21191411.
36. Yu J, Mitsui T, Wei M, Mao H, Butchar JP, Shah MV, Zhang J, Mishra A, Alvarez-Breckenridge C, Liu X, Liu S, Yokohama A, Trotta R, Marcucci G, Benson DM, Loughran TP, Tridandapani S, Caligiuri MA. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest 2011, 121:1456-1470. 10.1172/JCI43242, 3069763, 21364281.
37. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011, 12:21-27.
38. Nair A, Frederick TJ, Miller SD. Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 2008, 65:2702-2720. 10.1007/s00018-008-8059-5, 2858316, 18516496.
39. Saikali P, Antel JP, Pittet CL, Newcombe J, Arbour N. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J Immunol 2010, 185:5693-5703. 10.4049/jimmunol.1002188, 20926794.
40. Alvarez-Buylla A, Garcia-Verdugo JM, Tramontin AD. A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci 2001, 2:287-293. 10.1038/35067582, 11283751.
41. Yonezawa T, Ohtsuka A, Yoshitaka T, Hirano S, Nomoto H, Yamamoto K, Ninomiya Y. Limitrin, a novel immunoglobulin superfamily protein localized to glia limitans formed by astrocyte endfeet. Glia 2003, 44:190-204. 10.1002/glia.10279, 14603461.
42. Shapiro L, Love J, Colman DR. Adhesion molecules in the nervous system: structural insights into function and diversity. Annu Rev Neurosci 2007, 30:451-474. 10.1146/annurev.neuro.29.051605.113034, 17600523.
43. Crossin KL, Krushel LA. Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily. Dev Dyn 2000, 218:260-279. 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9, 10842356.
44. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?. Brain 2002, 125:1972-1979. 10.1093/brain/awf216, 12183343.
45. Bonfanti L. PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol 2006, 80:129-164. 10.1016/j.pneurobio.2006.08.003, 17029752.
46. Trotter J, Bitter-Suermann D, Schachner M. Differentiation-regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin. J Neurosci Res 1989, 22:369-383. 10.1002/jnr.490220402, 2668542.
47. Nomura T, Yabe T, Rosenthal ES, Krzan M, Schwartz JP. PSA-NCAM distinguishes reactive astrocytes in 6-OHDA-lesioned substantia nigra from those in the striatal terminal fields. J Neurosci Res 2000, 61:588-596. 10.1002/1097-4547(20000915)61:6<588::AID-JNR2>3.0.CO;2-M, 10972955.
48. Ricard CS, Kobayashi S, Pena JD, Salvador-Silva M, Agapova O, Hernandez MR. Selective expression of neural cell adhesion molecule (NCAM)-180 in optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. Brain Res Mol Brain Res 2000, 81:62-79.
49. Singhrao SK, Neal JW, Newman GR. Corpora amylacea could be an indicator of neurodegeneration. Neuropathol Appl Neurobiol 1993, 19:269-276. 10.1111/j.1365-2990.1993.tb00437.x, 8355813.
50. Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 1995, 26:816-823. 10.1016/0046-8177(95)90001-2, 7635444.
51. Kimura T, Fujise N, Ono T, Shono M, Yuzuriha T, Katsuragi S, Takamatsu J, Miyakawa T, Kitamura T. Identification of an aging-related spherical inclusion in the human brain. Pathol Int 2002, 52:636-642. 10.1046/j.1440-1827.2002.01402.x, 12445135.
52. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997, 56:1269-1275. 10.1097/00005072-199712000-00001, 9413275.
53. Selmaj K, Pawlowska Z, Walczak A, Koziolkiewicz W, Raine CS, Cierniewski CS. Corpora amylacea from multiple sclerosis brain tissue consists of aggregated neuronal cells. Acta Biochim Pol 2008, 55:43-49.